Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
Slobodan M JankovicPharmacology Department, Medical Faculty, University of Kragujevac, Kragujevac, SerbiaAbstract: Multiple sclerosis (MS) is chronic inflammatory and demyelinating disease with either a progressive (10%–15%) or relapsing-remitting (85%–90%) course. The pa...
Guardado en:
Autor principal: | Slobodan M Jankovic |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5b85b4be0c234d4daefdbd2f0a9208a1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Expression analysis of protein inhibitor of activated STAT (PIAS) genes in IFNβ-treated multiple sclerosis patients [Corrigendum]
por: Taheri M, et al.
Publicado: (2019) -
Alemtuzumab in the treatment of multiple sclerosis
por: Fernandez Ó
Publicado: (2014) -
Emerging therapies for treatment of multiple sclerosis
por: John R Corboy, et al.
Publicado: (2010) -
The effect of smoking on the symptoms and progression of multiple sclerosis: a review
por: Afsaneh Shirani, et al.
Publicado: (2010) -
Vascular involvement in systemic sclerosis (scleroderma)
por: Pattanaik D, et al.
Publicado: (2011)